RxDoctor Payments Data

Lawrence Blanchard, MD

Dermatology · Richmond, VANPI 1740280379

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 98.6% of the total across 45 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 10 manufacturers reported payments, led by LEO Pharma Inc. at 34.0% of the total. 2025 is the largest year on record at $464, more than ten times the $15 reported in 2020. That places this record below the midpoint for dermatology clinicians in VA, where the typical reported total is $1,785.

$917in general payments, 2019–2025

Across 45 payments — averaging $20.37 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • LEO Pharma Inc.$312
  • Arcutis Biotherapeutics, Inc.$178
  • AbbVie$116
  • Novartis$88
  • Galderma Laboratories, L.p.$68
  • Organon$58
  • plus $98 from 4 others

What the payments were for

  • Food & beverage$90499%
  • Education$131%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$917 in reported general payments places this provider in the 35th percentile of 396 dermatology providers in Virginia.

See all dermatology providers in Virginia →

Medicare billing

Part B allowed, 2024
$687,748
Medicare patients
1,860
Services billed
12,359

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Dupixent PenDupilumab17$62,819
Clobetasol Propionate96$4,541
Betamethasone Dipropionate97$4,405
Acitretin21$3,784
Minocycline Hcl170$3,578
Metronidazole64$3,549
ValacyclovirValacyclovir Hcl65$2,358
Desonide40$1,656
Ketoconazole82$1,627
Fluocinonide49$1,564
Triamcinolone Acetonide111$1,420
Clindamycin Phosphate54$1,267
Doxycycline Monohydrate45$1,240
Tretinoin13$1,236
Mometasone Furoate84$1,211

Paid to pharmacies, not to this prescriber.

Other dermatology in Richmond

See the full list for Virginia →

Where these figures come from

Is this you, or does something look wrong? →